Weill Cornell Medicine was awarded a five-year, $11.3 million Specialized Programs of Research Excellence grant from NCI to improve the detection, diagnosis and treatment of prostate cancer.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
